Virological failure rates and HIV‐1 drug resistance patterns in patients on first‐line antiretroviral treatment in semirural and rural Gabon

F Liégeois, C Vella, S Eymard‐Duvernay… - Journal of the …, 2012 - Wiley Online Library
Introduction As antiretroviral treatment (ART) continues to expand in resource‐limited
countries, the emergence of HIV drug resistance mutations (DRMs) is challenging in these …

Pretreatment and acquired antiretroviral drug resistance among persons living with HIV in four African countries

TA Crowell, B Danboise, A Parikh… - Clinical Infectious …, 2021 - academic.oup.com
Background Emerging HIV drug resistance (HIVDR) could jeopardize the success of
standardized HIV management protocols in resource-limited settings. We characterized …

Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies

RL Hamers, KCE Sigaloff, AM Wensing… - Clinical infectious …, 2012 - academic.oup.com
Background. Human immunodeficiency virus type 1 (HIV-1) drug resistance may limit the
benefits of antiretroviral therapy (ART). This cohort study examined patterns of drug …

HIV-1 drug-resistance surveillance among treatment-experienced and-naïve patients after the implementation of antiretroviral therapy in Ghana

NI Nii-Trebi, S Ibe, JS Barnor, K Ishikawa… - PLoS one, 2013 - journals.plos.org
Background Limited HIV-1 drug-resistance surveillance has been carried out in Ghana since
the implementation of antiretroviral therapy (ART). This study sought to provide data on the …

Virological outcome and patterns of HIV‐1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon

AF Aghokeng, C Kouanfack… - Journal of the …, 2013 - Wiley Online Library
Introduction The current expansion of antiretroviral treatment (ART) in the developing world
without routine virological monitoring still raises concerns on the outcome of the strategy in …

[PDF][PDF] Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in …

L Vergne, G Malonga-Mouellet, I Mistoul… - 2002 - horizon.documentation.ird.fr
The protease and reverse transcriptase (RT) genes were studied in antiretroviral (ARV)-
experienced and drug-naive HIV-I-infected individuals in Libreville, Gabon. We have shown …

HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda

JA Ndahimana, DJ Riedel, R Muhayimpundu… - 2016 - journals.sagepub.com
Background Studies of patients failing second-line antiretroviral therapy (ART) in resource-
limited settings (RLS) are few. Evidence suggests most patients who appear to be …

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

A Abdissa, D Yilma, J Fonager, AM Audelin… - BMC infectious …, 2014 - Springer
Background The ongoing scale-up of antiretroviral therapy (ART) in sub-Saharan Africa has
prompted the interest in surveillance of transmitted and acquired HIV drug resistance …

Rate and predictors of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es Salaam, Tanzania

FG Samizi, OD Panga, SS Mulugu, CG Gitige… - The Journal of Infection …, 2021 - jidc.org
Introduction: Monitoring resistance to first line Antiretroviral therapy (ART) is crucial in
preventing accumulation of viral mutations following the implementation of the World Health …

HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study

AS Hassan, HM Nabwera, SM Mwaringa… - AIDS research and …, 2014 - Springer
Background An increasing number of people on antiretroviral therapy (ART) in sub-Saharan
Africa has led to declines in HIV related morbidity and mortality. However, virologic failure …